{"id":"tp-53424","type":"article-newspaper","title":"MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53424","datePublished":"2026-11-11T00:12:27.000Z","dateModified":"2026-11-11T00:12:27.000Z","language":"en","abstract":"The company expects its $481.6 million in cash and investments to support operations into 2029.","section":"Business","references":[]}